Clinical Trials Directory

Trials / Completed

CompletedNCT03754127

A Randomized Controlled HD-tDCS Trial: Effects on Tinnitus Severity and Cognition

A Comparative, Randomized Trial on HD-tDCS and Sham Control Group: Effects on Tinnitus Severity and Cognition Including Objective Measures.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This randomized, placebo-controlled study will compare the effects of HD-tDCS (a non-invasive neuromodulation technique) with a sham stimulation. In the sham situation, patients will undergo an identical treatment but no stimulation will be applied, allowing to control for placebo effects. This study will assess the effects of HD-tDCS on chronic, non-pulsatile tinnitus in a reliable way, as confounding factors such as anxiety, depression, hearing impairment, tinnitus gradation, age, and sex will be controlled for. Ultimately, this study will result in final recommendations for a standardised protocol for the use of HD-tDCS in tinnitus patients. When accurate, individualised, and effective therapy is available for the patient, the total cost (both economical and personal) will decrease significantly. The investigation's findings will be relevant for all caretakers dealing with tinnitus patients (psychologists, psychiatrists, manual therapists, general practitioners, ENT specialists, audiologists, etc.).

Conditions

Interventions

TypeNameDescription
DEVICEtDCSTranscranial direct current stimulation
DEVICEsham tDCSSham transcranial direct current stimulation

Timeline

Start date
2019-01-01
Primary completion
2021-12-22
Completion
2022-03-30
First posted
2018-11-27
Last updated
2022-07-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03754127. Inclusion in this directory is not an endorsement.